Investigational Drug Information for reldesemtiv
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug reldesemtiv?
reldesemtiv is an investigational drug.
There have been 6 clinical trials for reldesemtiv.
The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2022.
The most common disease conditions in clinical trials are Amyotrophic Lateral Sclerosis, Sclerosis, and Motor Neuron Disease. The leading clinical trial sponsors are Cytokinetics, Astellas Pharma Global Development, Inc., and Astellas Pharma Inc.
There are eight US patents protecting this investigational drug and ninety-seven international patents.
Summary for reldesemtiv
| US Patents | 8 |
| International Patents | 97 |
| US Patent Applications | 33 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 7 |
| Clinical Trial Progress | Phase 2 (2022-07-01) |
| Vendors | 9 |
Recent Clinical Trials for reldesemtiv
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) | Cytokinetics | Phase 3 |
| A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) | Cytokinetics | Phase 3 |
| A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) | Astellas Pharma Inc | Phase 2 |
Clinical Trial Summary for reldesemtiv
Top disease conditions for reldesemtiv
Top clinical trial sponsors for reldesemtiv
US Patents for reldesemtiv
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| reldesemtiv | See Plans and Pricing | Substituted pyridazines as skeletal muscle modulators | CYTOKINETICS, INC. (South San Francisco, CA) | See Plans and Pricing |
| reldesemtiv | See Plans and Pricing | Amino-pyrimidine skeletal muscle modulators | Cytokinetics, Inc. (South San Francisco, CA) | See Plans and Pricing |
| reldesemtiv | See Plans and Pricing | Amino-pyrimidine skeletal muscle modulators | CYTOKINETICS, INC. (South San Francisco, CA) | See Plans and Pricing |
| reldesemtiv | See Plans and Pricing | Certain amino-pyrimidines, compositions thereof, and methods for their use | Cytokinetics, Inc. (South San Francisco, CA) | See Plans and Pricing |
| reldesemtiv | See Plans and Pricing | Amino-pyridazine skeletal muscle modulators | Cytokinetics, Inc. (South San Francisco, CA) | See Plans and Pricing |
| reldesemtiv | See Plans and Pricing | Certain amino-pyrimidines, compositions thereof, and methods for their use | Cytokinetics, Inc. (South San Francisco, CA) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for reldesemtiv
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| reldesemtiv | Argentina | AR081331 | 2030-04-23 | See Plans and Pricing |
| reldesemtiv | Argentina | AR081626 | 2030-04-23 | See Plans and Pricing |
| reldesemtiv | Australia | AU2011242569 | 2030-04-23 | See Plans and Pricing |
| reldesemtiv | Australia | AU2011242575 | 2030-04-23 | See Plans and Pricing |
| reldesemtiv | Australia | AU2016202617 | 2030-04-23 | See Plans and Pricing |
| reldesemtiv | Australia | AU2018201953 | 2030-04-23 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
